COMMUNIQUÉS West-GlobeNewswire

Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome

11/03/2025 - 13:33

LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience ( www.kaerusbio.com ), a clinical-stage biopharmaceutical company created by Medicxi for the development of therapeutics for rare genetic syndromes of [...]

Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline

11/03/2025 - 13:34

• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic modalities. WEXFORD, Pa., [...]

GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule

11/03/2025 - 13:35

LA JOLLA, CA, March 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]

AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

11/03/2025 - 13:45

On-demand video webcast now available Includes latest updates on pancreatic cancer and bird flu clinical trials OCALA, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “ [...]

Little Leaves Behavioral Services Expands in Maryland and Virginia

11/03/2025 - 13:51

Four new ABA therapy centers will open this summer to meet growing need for high-quality, early intervention resources for young children with autism SILVER SPRING, Md., March 11, 2025 (GLOBE NEWSWIRE) -- Little Leaves [...]

AMPS Launches ClaimInsight: A Next-Generation Payment Integrity Suite Built for Accuracy, Speed, and Value

11/03/2025 - 14:00

PHOENIX, March 11, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (AMPS), a leader in healthcare cost containment and payment integrity solutions, today announced the launch of ClaimInsight , a cutting-edge [...]

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

11/03/2025 - 14:00

Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq [...]

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

11/03/2025 - 14:00

Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading [...]

Woodstock Sterile Solutions Invests $8 million in New Automated, High-Speed, State-of-the-Art, Bottle Packaging Line

11/03/2025 - 14:00

Investment Reinforces Woodstock’s Commitment to Growth and Operating Efficiency WOODSTOCK, Ill., March 11, 2025 (GLOBE NEWSWIRE) -- Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and [...]

Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19

11/03/2025 - 14:00

Company to Host Conference Call, March 19, 2025 at 4:30 p.m. ET SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome- [...]

Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering

11/03/2025 - 14:03

The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation NEW YORK, March 11, 2025 (GLOBE [...]

Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction

11/03/2025 - 14:09

BOSTON, March 11, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next- [...]

HealthEquity Community Foundation Announces First Grant Recipients and Opens Next Funding Cycle

11/03/2025 - 14:15

Charitable non-profits nationwide receive grants to advance healthcare, financial literacy, mental health, and basic human needs; Applicants encouraged to apply for next round of funding DRAPER, Utah, March 11, 2025 ( [...]

Better Choice Company Signs Binding Letter of Intent to Acquire Choice Specialty Pharmacy, Expanding U.S. Presence

11/03/2025 - 14:15

TAMPA, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it has signed a binding [...]

Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting

11/03/2025 - 15:00

HOUSTON, March 11, 2025 (GLOBE NEWSWIRE) -- As Baylor Genetics celebrates a decade of leadership at the forefront of genetic testing, it is set to exhibit its latest scientific studies in genetic testing at the 2025 [...]

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025

11/03/2025 - 15:00

WOBURN, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the development and commercialization of dermatological products, today announced that it [...]

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

11/03/2025 - 16:00

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Surgeons Annual [...]

OSE Immunotherapeutics et le GERCOR annoncent des premiers résultats cliniques positifs de OSE2101 (Tedopi®) dans l’essai clinique de Phase 2 TEDOPaM dans le cancer du pancréas avancé

11/03/2025 - 18:00

OSE Immunotherapeutics et le GERCOR annoncent des premiers résultats cliniques positifs de OSE2101 (Tedopi®) dans l’essai clinique de Phase 2 TEDOPaM dans le cancer du pancréas avancé Critère principal atteint dans l’ [...]

OSE Immunotherapeutics and GERCOR Announce Positive Topline Phase 2 Result for Clinical Trial TEDOPaM Evaluating OSE2101 (Tedopi®) in Advanced Pancreatic Cancer

11/03/2025 - 18:00

OSE Immunotherapeutics and GERCOR Announce Positive Topline Phase 2 Result for Clinical Trial TEDOPaM Evaluating OSE2101 (Tedopi®) in Advanced Pancreatic Cancer Primary endpoint met in randomized Phase 2 trial [...]